Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5183081 | 0.89 | POLB (0.39) | POLBGABRA1GABRB2TDP1SRD5A1 | |
| SCHEMBL367941 | 0.86 | GABRA1 (0.44) | POLBGABRA1GABRB2ELANE | |
| SCHEMBL7107164 | 0.84 | GABRA1 (0.43) | POLBGABRA1GABRB2ELANE | |
| Magnesium SCHEMBL2052962 | 0.84 | GABRA1 (0.43) | POLBGABRA1GABRB2ELANE | |
| SCHEMBL2059595 | 0.80 | POLB (0.33) | POLB | |
| SCHEMBL11764994 | 0.80 | POLB (0.40) | POLBGABRA1GABRB2 | |
| SCHEMBL1918099 | 0.79 | GABRA1 (0.43) | POLBGABRA1GABRB2SRD5A1 | |
| Trolamine SCHEMBL28619894 | 0.79 | GABRA1 (0.36) | POLBGABRA1GABRB2 | |
| SCHEMBL27660929 | 0.79 | POLB (0.39) | POLBGABRA1GABRB2TDP1ELANE | |
| Sulfuric Acid SCHEMBL3191044 | 0.79 | IMPDH2 (0.40) | POLBGABRA1GABRB2SRD5A1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11920103-B2 | Mineral-oil-free lubricant and method for producing a mineral-oil-free lubricant | Kajo GmbH (DE) | 2024-03-05 | — | — | US | claimed |
| CN-113366096-B | Mineral oil-free lubricant and method of making a mineral oil-free lubricant | 卡乔有限责任公司 | 2023-03-17 | — | — | CN | claimed |
| US-20220056365-A1 | Mineral-Oil-Free Lubricant And Method For Producing A Mineral-Oil-Free Lubricant | Kajo GmbH (DE) | 2022-02-24 | — | — | US | claimed |
| CN-113366096-A | Mineral oil-free lubricant and method of making a mineral oil-free lubricant | 卡乔有限责任公司 | 2021-09-07 | — | — | CN | claimed |
| US-5368776-A | Corrosion protection additives based on epoxides | RHEIN CHEMIE RHEINAU GMBH (DE) | 1994-11-29 | — | — | US | claimed |
| US-11920103-B2 | Mineral-oil-free lubricant and method for producing a mineral-oil-free lubricant | Kajo GmbH (DE) | 2024-03-05 | — | — | US | disclosed |
| CN-113366096-B | Mineral oil-free lubricant and method of making a mineral oil-free lubricant | 卡乔有限责任公司 | 2023-03-17 | — | — | CN | disclosed |
| US-20220056365-A1 | Mineral-Oil-Free Lubricant And Method For Producing A Mineral-Oil-Free Lubricant | Kajo GmbH (DE) | 2022-02-24 | — | — | US | disclosed |
| CN-113366096-A | Mineral oil-free lubricant and method of making a mineral oil-free lubricant | 卡乔有限责任公司 | 2021-09-07 | — | — | CN | disclosed |
| US-7365066-B2 | Pyrazolopyridine derivatives as pharmaceutical agents | ELI LILLY AND COMPANY (US) | 2008-04-29 | — | — | US | disclosed |
| EP-1543001-B1 | PYRAZOLOPYRIDINE DERIVATIVES AS TGF BETA SIGNAL TRANSDUCTION INHIBITORS FOR THE TREATMENT OF CANCER | LILLY CO ELI (US) | 2007-08-15 | — | — | EP | disclosed |
| US-20050222197-A1 | Novel pyrazolopyridine derivatives as pharmaceutical agents | BEIGHT DOUGLAS W | 2005-10-06 | — | — | US | disclosed |
| EP-1543001-A1 | NOVEL PYRAZOLOPYRIDINE DERIVATIVES AS PHARMACEUTICAL AGENTS | ELI LILLY AND COMPANY (US) | 2005-06-22 | — | — | EP | disclosed |
| WO-2004026871-A1 | NOVEL PYRAZOLOPYRIDINE DERIVATVES AS PHARMACEUTICAL AGENTS | ELI LILLY AND COMPANY (US) | 2004-04-01 | — | — | WO | disclosed |
| US-4842067-A | USING MIXTURE OF SULFONATED SURFACTANTS | HUELS AKTIENGESELLSCHAFT (DE) | 1989-06-27 | — | — | US | disclosed |
| US-4705110-A | SALTS OF CARBOXYMETHYLATED OXYETHYLATES | HUELS AKTIENGESELLSCHAFT (DE) | 1987-11-10 | — | — | US | disclosed |
| US-3957425-A | DISAZO DYES, SOLVENT DYES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222197-A1 | Novel pyrazolopyridine derivatives as pharmaceutical agents | TGFB2, TGFB1, TGFBR1 | POLB 1643/4885GABRA1 3056/4885GABRB2 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.